ClinicalTrials.gg
Not yet recruitingNCT07545733PROPEEPUpdated Nov 16, 2026

Comparison of 5 vs 8 cmH₂O PEEP on Respiratory Mechanics in Prone Lumbar Surgery

An interventional study of Mechanical Ventilation (PEEP) in Lumbar Disc Herniation, Spinal Surgery and Prone Position, sponsored by Harran University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Harran University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 16, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This randomized controlled clinical trial aims to compare the effects of two different positive end-expiratory pressure (PEEP) levels (5 cmH₂O and 8 cmH₂O) on respiratory mechanics in patients undergoing lumbar spine surgery in the prone position under total intravenous anesthesia (TIVA). Prone positioning may adversely affect lung compliance and gas exchange, making optimal ventilatory strategies essential. Driving pressure and mechanical power are considered key determinants of ventilator-induced lung stress. This study will evaluate the impact of different PEEP levels on respiratory parameters and intraoperative physiological changes.

Read the detailed description

Prone positioning during lumbar spine surgery is associated with increased intrathoracic pressure, reduced lung compliance, and impaired ventilation-perfusion matching, which may negatively affect respiratory mechanics and gas exchange. Mechanical ventilation strategies, particularly the application of positive end-expiratory pressure (PEEP), play a critical role in preventing atelectasis and optimizing oxygenation.

Pressure-controlled ventilation with volume guarantee (PCV-VG) is a modern ventilation mode that ensures target tidal volume delivery while minimizing airway pressures, thereby reducing the risk of ventilator-induced lung injury. In recent years, driving pressure (ΔP) and mechanical power have emerged as important parameters reflecting lung stress and injury during mechanical ventilation.

This prospective randomized controlled trial aims to evaluate the effects of two different PEEP levels (5 cmH₂O and 8 cmH₂O) on respiratory mechanics and gas exchange in patients undergoing lumbar spine surgery in the prone position under total intravenous anesthesia (TIVA). Patients will be randomly assigned into two groups receiving either 5 cmH₂O or 8 cmH₂O PEEP. Ventilation will be standardized using PCV-VG mode with a tidal volume of 6-8 mL/kg predicted body weight and respiratory rate adjusted to maintain normocapnia.

Hemodynamic parameters and respiratory variables, including peak airway pressure, plateau pressure, dynamic compliance, airway resistance, tidal volume, and end-tidal CO₂, will be recorded at predefined time points. Arterial blood gas analyses will be performed at selected intervals to assess gas exchange.

The primary outcome of the study is driving pressure (ΔP), while secondary outcomes include mechanical power, oxygenation parameters, PaCO₂-EtCO₂ gradient, and physiologic dead space fraction (VD/VT).

The findings of this study are expected to provide clinical evidence regarding the optimal PEEP level in prone lumbar surgery and contribute to improving intraoperative lung-protective ventilation strategies.

02

Conditions studied

  • Lumbar Disc Herniation
  • Spinal Surgery
  • Prone Position
  • General Anesthesia

Keywords

  • PEEP
  • Driving Pressure
  • Mechanical Power
  • PCV-VG Ventilation
  • Prone Position
  • Lung Protective Ventilation
03

In context

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.

This study's planned enrollment of 60 is close to the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Harran University is the lead sponsor of 64 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged between 18 and 65 years
  • (ASA) physical status I-II
  • Scheduled for elective lumbar spine surgery in the prone position
  • Planned general anesthesia with total intravenous anesthesia (TIVA)
  • Ability to provide

Exclusion criteria

Exclusion Criteria:

  • (BMI) ≥ 30 kg/m²
  • History of significant pulmonary disease (e.g., , asthma)
  • Severe cardiovascular disease
  • Pregnancy
  • Known difficult airway
  • Requirement for intraoperative vasopressor infusion due to hemodynamic instability
  • Conversion to different surgical position or change in surgical plan
  • Incomplete data or protocol deviation
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    PEEP-5 Group

    Participants in this group will receive mechanical ventilation with a positive end-expiratory pressure (PEEP) level of 5 cmH₂O during lumbar spine surgery in the prone position under total intravenous anesthesia (TIVA). Ventilation will be performed using PCV-VG mode with a target tidal volume of 6-8 mL/kg predicted body weight and respiratory rate adjusted to maintain normocapnia.

    Device: Mechanical Ventilation (PEEP)

  • Experimental
    PEEP-8 Group

    Participants in this group will receive mechanical ventilation with a positive end-expiratory pressure (PEEP) level of 8 cmH₂O during lumbar spine surgery in the prone position under total intravenous anesthesia (TIVA). Ventilation will be performed using PCV-VG mode with a target tidal volume of 6-8 mL/kg predicted body weight and respiratory rate adjusted to maintain normocapnia.

    Device: Mechanical Ventilation (PEEP)

Interventions

  • DeviceMechanical Ventilation (PEEP)

    Mechanical ventilation will be applied using pressure-controlled ventilation with volume guarantee (PCV-VG) mode during prone lumbar surgery under total intravenous anesthesia (TIVA). Two different positive end-expiratory pressure (PEEP) levels (5 cmH₂O and 8 cmH₂O) will be used according to group allocation. Tidal volume will be set at 6-8 mL/kg predicted body weight, and respiratory rate will be adjusted to maintain normocapnia (EtCO₂ 35-40 mmHg).

    Also known as: PCV-VG Ventilation, Lung Protective Ventilation

06

What researchers measure

Primary outcomes

  1. Driving Pressure (ΔP)

    Driving pressure (ΔP), calculated as the difference between plateau pressure (Pplat) and positive end-expiratory pressure (PEEP), will be used as the primary outcome to assess lung stress during mechanical ventilation.

    Time frame: Intraoperative period (at predefined time points: T0, T2, T5)

Secondary outcomes

  1. Mechanical Power

    Mechanical power will be calculated to quantify the energy delivered to the respiratory system during mechanical ventilation.

    Time frame: Intraoperative period (T0, T2, T5)

  2. Oxygenation (PaO₂/FiO₂ Ratio)

    Oxygenation status will be assessed using the arterial oxygen partial pressure to inspired oxygen fraction (PaO₂/FiO₂) ratio.

    Time frame: Intraoperative period (T0, T2, T5)

  3. PaCO₂-EtCO₂ Gradient

    The difference between arterial carbon dioxide pressure (PaCO₂) and end-tidal CO₂ (EtCO₂) will be used to evaluate ventilation-perfusion mismatch.

    Time frame: Intraoperative period (T0, T2, T5)

  4. Physiological Dead Space Fraction (VD/VT)

    Physiological dead space fraction will be calculated using the Bohr equation to assess ventilation efficiency.

    Time frame: Intraoperative period (T0, T2, T5)

  5. Dynamic Lung Compliance (Cdyn)

    Dynamic compliance will be recorded to evaluate changes in lung mechanics during ventilation.

    Time frame: Intraoperative period (all time points)

  6. Peak Airway Pressure (Ppeak)

    Peak airway pressure will be recorded to assess airway pressure changes during mechanical ventilation.

    Time frame: Intraoperative period (all time points)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: start Aug 2026 → Nov 2026, primary completion Sep 2026 → Jan 2027 and completion Oct 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2026
First posted
Apr 22, 2026
StartEst.
Nov 15, 2026was Aug 2026
Primary completionEst.
Jan 31, 2027was Sep 2026
CompletionEst.
Mar 3, 2027was Oct 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 15, 2026→Nov 15, 2026
Nov 16, 2026
Primary completion
Sep 2, 2026→Jan 31, 2027
Nov 16, 2026
Study completion
Oct 3, 2026→Mar 3, 2027
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Start date Aug 15, 2026→Nov 15, 2026
    Primary completion Sep 2, 2026→Jan 31, 2027
    Study completion Oct 3, 2026→Mar 3, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07545733
Lead sponsor
Harran University
Responsible party
Veli Fahri Pehlivan (Assistant Professor, Harran University) — Principal investigator
First posted
Apr 22, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Jan 31, 2027 (estimated)
Completion
Mar 3, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Basak Pehlivan, Assoc Prof
Contact
bpehlivan@harran.edu.tr
5054083199
Veli F Pehlivan, MD
Contact
vfpehlivan@harran.edu.tr
5327696566
Basak Pehlivan, Asoc Prof
principal investigator · Harran University Faculty of Medicine, Department of Anesthesiology

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion